Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

31,229 signal articles · 0 in last 24h · 160,153 total before filter · latest 1d ago
0last 24h
599last 7d
87● bullish (7d)
64● bearish (7d)
214publishers
AllMacro110Earnings164M&A62Regulatory12Product10Analyst17
✕ clear all filtersticker: ^GSPCSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
3 Reasons BOW Has Explosive Upside Potential
StockStory108d agoneutral
3 Reasons BOW Has Explosive Upside Potential

Bowhead Specialty has been treading water for the past six months, recording a small loss of 1.8% while holding steady at $27.22. The stock also fell short of the S&P 500’s 9.3% gain during that period.

3 Reasons to Avoid BCC and 1 Stock to Buy Instead
StockStory108d agobullish
3 Reasons to Avoid BCC and 1 Stock to Buy Instead

Since December 2025, Boise Cascade has been in a holding pattern, posting a small loss of 4.9% while floating around $72.09. The stock also fell short of the S&P 500’s 9.3% gain during that period.

Boeing (BA): Buy, Sell, or Hold Post Q1 Earnings?
StockStory108d agoneutral
Boeing (BA): Buy, Sell, or Hold Post Q1 Earnings?

Boeing has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 10.6% to $228.58 per share while the index has gained 9.3%.

3 Reasons ESAB is Risky and 1 Stock to Buy Instead
StockStory108d agobullish
3 Reasons ESAB is Risky and 1 Stock to Buy Instead

Over the past six months, ESAB’s shares (currently trading at $97) have posted a disappointing 15.2% loss, well below the S&P 500’s 9.3% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.

3 Reasons to Sell SGRY and 1 Stock to Buy Instead
StockStory108d agoneutral
3 Reasons to Sell SGRY and 1 Stock to Buy Instead

Surgery Partners currently trades at $15.10 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell short of the S&P 500’s 9.3% gain during that period.

Anthropic heads to Washington to win its AI models back
TheStreet108d agoneutral
Anthropic heads to Washington to win its AI models back

Markets like to believe that size is a kind of armor. The bigger a company gets, the safer it looks, until it stops feeling like a business and starts feeling like part of the furniture of the economy itself. That belief is doing a lot of work right now. Investors have spent the past two years ...

3 Reasons to Avoid ETSY and 1 Stock to Buy Instead
StockStory108d agobullish
3 Reasons to Avoid ETSY and 1 Stock to Buy Instead

Over the past six months, Etsy has been a great trade, beating the S&P 500 by 24%. Its stock price has climbed to $71.62, representing a healthy 33.2% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

2 Reasons to Like SYBT (and 1 Not So Much)
StockStory108d agoneutral
2 Reasons to Like SYBT (and 1 Not So Much)

Stock Yards Bank trades at $73.37 per share and has stayed right on track with the overall market, gaining 6.3% over the last six months. At the same time, the S&P 500 has returned 9.3%.

3 Reasons OPLN is Risky and 1 Stock to Buy Instead
StockStory108d agobullish
3 Reasons OPLN is Risky and 1 Stock to Buy Instead

OPENLANE’s 28.3% return over the past six months has outpaced the S&P 500 by 19%, and its stock price has climbed to $38.46 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

2 S&P 500 Stocks for Long-Term Investors and 1 We Question
StockStory108d agoneutral
2 S&P 500 Stocks for Long-Term Investors and 1 We Question

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

Morgan Stanley issues verdict for nervous stock market investors
TheStreet108d agoneutral
Morgan Stanley issues verdict for nervous stock market investors

Investors had been bracing for a deeper stock-market reset after the latest pullback exposed the cracks beneath the surface. Morgan Stanley says that fears might be going too far. According to a note shared with me, strategist Michael Wilson said the correction underscores a normal shift inside an ...